Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Study: Hydroxychloroquine not warranted for hospitalized COVID-19 patients 

By Brian Buntz | November 11, 2020

Hydroxychloroquine

[Image courtesy of Wikipedia]

A National Institutes of Health clinical trial has concluded that hydroxychloroquine had no clinical benefit for hospitalized COVID-19 patients.

The Journal of the American Medical Association published the results from the blinded, placebo-controlled, randomized trial.

The clinical trial, known as the “ORCHID” study, treated 479 symptomatic COVID-19 patients with hydroxychloroquine in 34 hospitals in the U.S. Clinical trial volunteers received either 10 doses of hydroxychloroquine or a placebo for five days. Researchers then evaluated their clinical status 14 days after the completion of the treatment phase.

Researchers found that the placebo and hydroxychloroquine arms had similar trial outcomes, which took place from April 2 and June 19, 2020. The findings “do not support the use of hydroxychloroquine for treatment of COVID-19 among hospitalized adults,” the study authors concluded.

Hydroxychloroquine, an anti-malarial drug, had come into prominence earlier this year after in vitro studies showed promise against the novel coronavirus. By April, U.S. President Trump began advocating hydroxychloroquine as a COVID-19 treatment.

Clinical evidence regarding the drug was less promising. One study published in the New England Journal of Medicine, for instance, found that hospitalized COVID-19 patients treated with the medication were slightly less likely to be discharged from the hospital than patients receiving the standard of care.

The White House would later order that HHS add 23 million hydroxychloroquine tablets to the Strategic National Stockpile as a potential COVID-19 treatment. The President reportedly pressured the FDA to grant an EUA for the drug, which the agency later revoked.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Doctor, woman patient and tablet for consulting with results, medical info and talk for healthcare with mockup space. Japanese medic, digital touchscreen or show video for surgery, wellness or advice.
Putting patients first in clinical trials
Confidently navigate the transition from bench to batch
Merck
FDA approves Merck’s Winrevair to treat pulmonary arterial hypertension
kobayashi pharmaceutical logo
Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE